A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Express Worries
However, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some experts stated the popularity for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, risking penalties, legal action or imprisonment.
Service Response and Content Elimination
According to the social media company, the platform has removed problematic content and banned associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Investigations also found groups with up to nine thousand members selling retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive reviews and detailed guides for preparing or injecting at home.
After moments of entering one community, a seller shared contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, medical conditions or past usage.
Item Details and Costs
Inside these groups, messages display dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for Telegram said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they can’t verify. Although the science behind retatrutide is sound, these online versions may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the increase in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has already encountered individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly serious health risks”.
